In this ADVENT symposium at the 2024 EADV meeting, Professor Joost Meijer highlights the heterogeneous nature of BP and the resultant burden for patients.
Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

Prof. Hellings and Prof. Corso explore the time frame to assess if the patient with CRSwNP has achieved remission

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.

Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.

Dr. Stephanie Christenson discusses the association between COPD exacerbations and the increased risks of morbidity and mortality
An infographic exploring the pathophysiology of prurigo nodularis and the role of type 2 inflammation.

An interactive tool used to explore the global burden of atopic dermatitis in children and adolescents.
In this video soundbite from the ERS-ISIAN 2025 symposium, Dr. Vibeke Backer discusses how Type 2 inflammation drives severe, uncontrolled CRSwNP. It covers key immune cells and biomarkers (e.g., IL-4, IL-5, IL-13, TSLP), global prevalence differences, and the importance of symptom tracking and targeted therapies.
Join experts Dédée Murrell, Donna Aline Culton, Joost Meijer and Enno Schmidt for an educational presentation on the clinical presentation, disease burden, diagnosis, and underlying pathophysiology of bullous pemphigoid (BP). Dive deeper into unmet needs and treatment challenges faced by these patients and how targeted therapies may address them.
Dr. Evan Dellon highlights how resolution of food impaction can be leveraged as an opportunity to diagnose EoE.
Dr. Elena Netchiporouk illustrates key considerations for diagnosing CSU at EADV 2025.